Skip to Content
Merck
  • Defective STIM-mediated store operated Ca2+ entry in hepatocytes leads to metabolic dysfunction in obesity.

Defective STIM-mediated store operated Ca2+ entry in hepatocytes leads to metabolic dysfunction in obesity.

eLife (2017-12-16)
Ana Paula Arruda, Benedicte Mengel Pers, Günes Parlakgul, Ekin Güney, Ted Goh, Erika Cagampan, Grace Yankun Lee, Renata L Goncalves, Gökhan S Hotamisligil
ABSTRACT

Defective Ca2+ handling is a key mechanism underlying hepatic endoplasmic reticulum (ER) dysfunction in obesity. ER Ca2+ level is in part monitored by the store-operated Ca2+ entry (SOCE) system, an adaptive mechanism that senses ER luminal Ca2+ concentrations through the STIM proteins and facilitates import of the ion from the extracellular space. Here, we show that hepatocytes from obese mice displayed significantly diminished SOCE as a result of impaired STIM1 translocation, which was associated with aberrant STIM1 O-GlycNAcylation. Primary hepatocytes deficient in STIM1 exhibited elevated cellular stress as well as impaired insulin action, increased glucose production and lipid droplet accumulation. Additionally, mice with acute liver deletion of STIM1 displayed systemic glucose intolerance. Conversely, over-expression of STIM1 in obese mice led to increased SOCE, which was sufficient to improve systemic glucose tolerance. These findings demonstrate that SOCE is an important mechanism for healthy hepatic Ca2+ balance and systemic metabolic control.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Na+/K+ ATPase α-1 Antibody, clone C464.6, Alexa Fluor 488, clone C464.6, Upstate®, from mouse
Sigma-Aldrich
PhosphoDetect Anti-Insulin Receptor (pTyr1162/1163) Rabbit pAb, liquid, Calbiochem®
Sigma-Aldrich
Monoclonal Anti-ORAI1 antibody produced in mouse, clone 3F6H5, purified immunoglobulin, buffered aqueous solution